Evidence map›Paper›PMID 42698217›Full record

ArticlePigment cell & melanoma research2026

A Technique for the Generation of Mucosal and Acral Melanoma Cell Lines.

Ishani Banik, Sugandha Basu, Meng Wang, Austin J Escobar, Veronica Steri, Juan A Camara Serrano, Paul Phojanakong, Noel Cruz Pacheco, Katy K Tsai, Edwin A Alvarez and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pigment cell & melanoma research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Ishani BanikDepartment of Dermatology, University of California, San Francisco, California, USA.ORCID https://orcid.org/0000-0002-7013-1132
Sugandha BasuDepartment of Dermatology, University of California, San Francisco, California, USA.
Meng WangDepartment of Dermatology, University of California, San Francisco, California, USA.
Austin J EscobarDepartment of Dermatology, University of California, San Francisco, California, USA.ORCID https://orcid.org/0000-0001-9410-6866
Veronica SteriUniversity of California, Pre-Clinical Therapeutics Core, San Francisco, California, USA.ORCID https://orcid.org/0000-0003-2499-6618
Juan A Camara SerranoUniversity of California, Pre-Clinical Therapeutics Core, San Francisco, California, USA.ORCID https://orcid.org/0000-0001-7494-1127
Paul PhojanakongUniversity of California, Pre-Clinical Therapeutics Core, San Francisco, California, USA.
Noel Cruz PachecoDepartment of Dermatology, University of California, San Francisco, California, USA.ORCID https://orcid.org/0000-0001-8989-7093
Katy K TsaiDepartment of Medicine, University of California, San Francisco, California, USA.ORCID https://orcid.org/0000-0002-7705-1813
Edwin A AlvarezDepartment of Obstetrics, Gynecology & Reproductive Sciences, University of California, San Francisco, California, USA.
Adil DaudDepartment of Medicine, University of California, San Francisco, California, USA.ORCID https://orcid.org/0000-0002-6617-8421
Ivan H El-SayedDepartment of Otolaryngology, University of California, San Francisco, California, USA.ORCID https://orcid.org/0000-0001-8121-3726
Anastasia SamarkinaDepartment of Dermatology, University of California, San Francisco, California, USA.ORCID https://orcid.org/0000-0003-1553-4366
Joy XuDepartment of Dermatology, University of California, San Francisco, California, USA.ORCID https://orcid.org/0000-0002-3233-2371
Jamie D AquinoDepartment of Dermatology, University of California, San Francisco, California, USA.
Min XiaoThe Wistar Melanoma Research Center, Philadelphia, Pennsylvania, USA.
Meenhard HerlynThe Wistar Melanoma Research Center, Philadelphia, Pennsylvania, USA.
Iwei YehDepartment of Dermatology, University of California, San Francisco, California, USA.ORCID https://orcid.org/0000-0002-3941-3561

Funding

Research Project 2 - Targeting Melanoma Tumor Survival and Apoptotic MachineryU54CA224070 · NCI · WISTAR INSTITUTE · PI Jessie Villanueva · 2017 to 2026
$13.9M
NCI NIH HHS R37CA249014NCI NIH HHS U54 CA224070U.S. Army Medical Research Acquisition Activity (USAMRAA) HT9425-24-1-0512
6 · The paper itself

Abstract

Mucosal and acral melanomas are rare subtypes of melanoma with unique clinical and biological features. A dearth of well-established and characterized melanoma cell lines that reflect rare subtypes impedes research on these lethal diseases. We present a protocol developed by exploring various combinations of established techniques that we used to generate mucosal and acral cell lines from patient tissues and patient derived xenografts.

Indexed as

Cell Culture TechniquesMelanomaMucous MembraneSkin NeoplasmsAnimalsCell Line, TumorHumansMice

Identifiers

PMID42698217
PMCPMC13545478

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.